Skip to menu Skip to content Skip to footer

Personalized immunotherapy for the treatment of light chain amyloidosis (2025-2027)

Experts

Professor Maher Gandhi

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Maher Gandhi
Maher Gandhi

Associate Professor Seth Cheetham

Director, National Biologics Facility and AIBN Group Leader
Australian Institute for Bioengineering and Nanotechnology
Seth Cheetham
Seth Cheetham